Live Breaking News & Updates on Sponsored Studies

Stay updated with breaking news from Sponsored studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023

New Repatha® (evolocumab) Data Show No Decline in Cognitive Function Associated With Very Low Levels of LDL-C Olpasiran Research Provides Further . ....

United States , Puerto Rico , Prnewswire Amgen , Jessica Akopyan , Arterioscler Thromb Vasc , Robert Giugliano , Clin Lipidol , Paul Burton , Justin Claeys , Madison Howard , Coll Cardiol , American Heart Association , Awareness To Action Implementation Consortium , Chemocentryx Inc , Olpasiran Research On Risks , European Union , Action Implementation Consortium , Exchange Commission , World Best Companies , Harvard Medical School , Kyowa Kirin Co Ltd , Study Group , Drug Administration , Teneobio Inc , Beigene Ltd , Technology Hall ,

AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023

AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

United States , Puerto Rico , Robert Giugliano , Madison Howard , Paul Burton , Arterioscler Thromb Vasc , Coll Cardiol , Justin Claeys , Prnewswire Amgen , Jessica Akopyan , Clin Lipidol , Olpasiran Research On Risks , Chemocentryx Inc , Action Implementation Consortium , European Union , Study Group , Harvard Medical School , Technology Hall , World Best Companies , Beigene Ltd , Teneobio Inc , Exchange Commission , American Heart Association , Awareness To Action Implementation Consortium , Kyowa Kirin Co Ltd , Drug Administration ,

AMGEN PRESENTS LATE-BREAKING PHASE 2 OLPASIRAN DATA AT ESC 2023

/PRNewswire/ Amgen (NASDAQ:AMGN) today announced data from the final analysis of the Phase 2 OCEAN(a)-DOSE study of olpasiran, a small interfering RNA. ....

Puerto Rico , United States , Noord Holland , Arterioscler Thromb Vasc , Clin Lipidol , Jessica Akopyan , Johns Hopkins , Coll Cardiol , C Michael Gibson , Prnewswire Amgen , Michellel Odonoghue , Justin Claeys , Paul Burton , Teneobio Inc , Beigene Ltd , Exchange Commission , Institute Of Clinical Research , Drug Administration , Harvard Medical School , Extension Program On Long , European Society Of Cardiology , Awareness To Action Implementation Consortium , Chemocentryx Inc , University Of Colorado , Kyowa Kirin Co Ltd , Innovative Lipid Management ,

AMGEN PRESENTS LATE-BREAKING PHASE 2 OLPASIRAN DATA AT ESC 2023

AMGEN PRESENTS LATE-BREAKING PHASE 2 OLPASIRAN DATA AT ESC 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Puerto Rico , United States , Noord Holland , Arterioscler Thromb Vasc , Justin Claeys , Johns Hopkins , Paul Burton , Prnewswire Amgen , Jessica Akopyan , C Michael Gibson , Coll Cardiol , Michellel Odonoghue , Clin Lipidol , Teneobio Inc , Beigene Ltd , Extension Program On Long , European Society Of Cardiology , Kyowa Kirin Co Ltd , Harvard Medical School , Exchange Commission , Institute Of Clinical Research , Chemocentryx Inc , University Of Colorado , Drug Administration , Awareness To Action Implementation Consortium , Innovative Lipid Management ,

NEW DATA SHOWCASES HOW AMGEN IS ADVANCING ALL ANGLES OF CANCER CARE THROUGH INNOVATIVE ONCOLOGY PORTFOLIO AND PIPELINE AT ASCO 2022

/PRNewswire/ Amgen (NASDAQ: AMGN) will present new data from across its broad oncology innovative medicines and biosimilars portfolio and robust pipeline at. ....

United States , Hong Kong , United Kingdom , United Arab Emirates , Puerto Rico , Saudi Arabia , South Korea , Great Britain , Megan Fox , Jessica Akopyan , Stevens Johnson , Spira Al , Davidm Reese , Kyowa Kirin Co Ltd , American Society Of Clinical Oncology , Drug Administration , Beigene Ltd , Takeda Pharmaceutical Company , Exchange Commission , Therapeutics Inc , European Union , Amgen Inc , Teneobio Inc , American Cancer Society , Results From , Ahead Trial ,